Seeing Is Believing
Currently out of the existing stock ratings of Chad Mabry, 32 are a BUY (96.97%), 1 are a HOLD (3.03%).
Analyst Chad Mabry works with a stock forecast success ratio of 42.59% fulfilled within 383.56 days on average. Previously, Chad Mabry worked at MLV.
Chad Mabry’s has documented 66 price targets and ratings displayed on 9 stocks. The coverage was on Energy, Healthcare sectors.
Most recent stock forecast was given on ALT, Altimmune at 07-Sep-2021.
Analyst best performing recommendations are on QEP (QEP RESOURCES).
The best stock recommendation documented was for QEP (QEP RESOURCES) at 7/21/2016. The price target of $19 was fulfilled within 25 days with a profit of $2.06 (12.16%) receiving and performance score of 4.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
38
$2.24 (6.26%)
60
2 months 7 days ago
0/9 (0%)
$7.17 (23.26%)
Hold
32
$-3.76 (-10.51%)
44
3 months 10 days ago
1/10 (10%)
$0.42 (1.33%)
1
Buy
45
$9.24 (25.84%)
51
3 months 25 days ago
7/22 (31.82%)
$10.47 (30.32%)
44
Hold
40
$4.24 (11.86%)
41
5 months 4 days ago
1/4 (25%)
$8.43 (26.70%)
45
40
$4.24 (11.86%)
41
5 months 4 days ago
5/14 (35.71%)
$8.43 (26.70%)
30
What Year was the first public recommendation made by Chad Mabry?